CAPTRUST Financial Advisors
AMPH icon

CAPTRUST Financial Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

CAPTRUST Financial Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,346
Closed -$207K – 2159
2023
Q4 		$207K Buy
+3,346
New +$176K ﹤0.01% 2376
2022
Q3 		– Sell
-2,990
Closed -$104K – 2139
2022
Q2 		$104K Buy
2,990
+220
+8% +$7.85K ﹤0.01% 2164
2022
Q1 		$99K Buy
2,770
+1,478
+114% +$41.9K ﹤0.01% 2275
2021
Q4 		$30K Buy
1,292
+110
+9% +$2.25K ﹤0.01% 3018
2021
Q3 		$22K Sell
1,182
-125
-10% -$2.45K ﹤0.01% 3083
2021
Q2 		$26K Sell
1,307
-185
-12% -$3.49K ﹤0.01% 2926
2021
Q1 		$27K Buy
1,492
+1,417
+1,889% +$26.3K ﹤0.01% 2809
2020
Q4 		$2K Buy
+75
New +$1.46K ﹤0.01% 3077

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

CAPTRUST Financial Advisors's AMPH Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2024, closing a stake of 3,346 shares — an estimated $207K sold.

CAPTRUST Financial Advisors first reported a position in AMPH in Q4 2020 and held it in 8 quarters. The position peaked at $207K in Q4 2023. 270 funds tracked by Wall St. Rank hold AMPH as of Q1 2024.

  • CAPTRUST Financial Advisors reported no remaining Amphastar Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 3,346 Amphastar Pharmaceuticals shares in Q1 2024, an estimated $207K.
  • CAPTRUST Financial Advisors first reported a position in Amphastar Pharmaceuticals in Q4 2020 and held it in 8 quarters.
  • CAPTRUST Financial Advisors's Amphastar Pharmaceuticals position peaked at $207K in Q4 2023.
  • 270 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.